When the American College of Radiology (ACR) published the Lung CT Screening Reporting and Data System (Lung-RADS) in 2014, one of its goals was producing a lower false-positive rate than the 23.3 percent reported by the National Cancer Institute’s National Lung Screening Trial (NLST).

Feeling the pressure from the ever-growing presence of Amazon in the healthcare space, CVS Health and Walgreens are emphasizing their abilities to connect with patients face to face, Forbes reported.

Shareholders of Cigna have approved a $67 billion acquisition of Express Scripts, a pharmacy benefit manager.

“As I start rank ordering the various charities I want to give to, the people who can pay for medical school in cash aren’t at the top of my list,” Craig Garthwaite, PhD, a health economist at Northwestern University, told Kaiser Health News.

The past several years have seen the development of a de facto stealth campaign against screening mammography. “Vast Study Casts Doubts on Value of Mammograms,” the New York Times bullhorned in 2014. “Why Getting a Mammogram May Cause More Trouble Than It’s Worth,” a Prevention headline blared in 2016. “It’s Time to End Mammograms, Some Experts Say,” trumpeted Time this past December. All of this is fueled, of course, by the never-ending disputes over guidelines issued by numerous authoritative groups.

The Affordable Care Act (ACA) is more popular than the recently enacted tax law, according to a poll from Fox News.

Understanding the power of being persuasive is important in any walk of life, including radiology. In a recent commentary for the Journal of the American College of Radiology, lead author Nupur Verma, MD, with the department of radiology at the University of Florida College of Medicine in Gainesville, and colleagues explained how being persuasive can help radiologists find success and get things done.

For patients with breast cancer, out-of-pocket costs can carry a heavy burden. According to a recent Journal of Supportive Care and Cancer study, those costs can last years after diagnosis—climbing higher for those with lymphedema.